Search

Your search keyword '"Wang, Lily"' showing total 1,967 results

Search Constraints

Start Over You searched for: Author "Wang, Lily" Remove constraint Author: "Wang, Lily"
1,967 results on '"Wang, Lily"'

Search Results

1. The Open Force Field Initiative: Open Software and Open Science for Molecular Modeling.

2. Gemini 1.5: Unlocking multimodal understanding across millions of tokens of context

3. Gemini: A Family of Highly Capable Multimodal Models

5. Improved Shortest Path Restoration Lemmas for Multiple Edge Failures: Trade-offs Between Fault-tolerance and Subpaths

6. Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2

7. EspalomaCharge: Machine learning-enabled ultra-fast partial charge assignment

9. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism

12. On Some Variants of Euclidean K-Supplier

18. Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features

20. Research on Space Project Systems Technological Risk Assessment Based on Multi-level Fuzzy Comprehensive Evaluation

21. Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders

22. Modeling COVID-19 Spread in Small Colleges

23. Online Generalized Network Design Under (Dis)Economies of Scale

25. Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors

26. Citizenship Bill Delayed: What's Next For Canadian Descendants?

28. Nature vs. Nurture: Dynamical Evolution in Disordered Ising Ferromagnets

30. ACR Appropriateness Criteria® Headache: 2022 Update

31. Ten questions concerning well-being in the built environment

32. Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)

33. FAIRshake: Toolkit to Evaluate the FAIRness of Research Digital Resources

39. Cep57 regulates human centrosomes through multivalent interactions

40. Characterization of complete responders to nivolumab + gemcitabine-cisplatin vs gemcitabine-cisplatin alone and patients with lymph node–only metastatic urothelial carcinoma from the CheckMate 901 trial.

43. PD34-11 NIVOLUMAB PLUS GEMCITABINE-CISPLATIN VERSUS GEMCITABINE-CISPLATIN ALONE IN PATIENTS WITH PREVIOUSLY UNTREATED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA: RESULTS OF ANALYSES TO CHARACTERIZE BENEFIT IN RESPONDERS FROM THE PHASE 3 CHECKMATE 901 TRIAL

Catalog

Books, media, physical & digital resources